Swiss bio-analytics startup
Rivia has raised €16M across 2 funding rounds from 6 investors, most recently a Series A round in Mar 2026. Based in Zurich, Switzerland; active in Software. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-03-18 | Series A | €13M | Amino Collective,Defiant,Earlybird,Nina Capital,SpeedInvest | View deal → |
| 2024-06-12 | Seed | €3.0M | Speedinvest | View deal → |
